Insulet Corporation Logo

Insulet Corporation (1PODD)

MTA

Currency in EUR
122.90
0.00 (0.00%)

Closed

Oct 2, 2026

Day's Range

122.90
122.90

52 wk Range

110.00
290.50

Overview - 1PODD - Insulet Corporation

Key Statistics

Valuation

Enterprise Value

7.66B

P/E (Trailing)

‪25.64‬

PEG Ratio

‪0.07‬

Price / Sales (TTM)

‪2.72‬

Price / Book

‪6.65‬

EV / EBITDA

‪14.20‬

Profitability

Gross Margin

‪70.17%‬

Profit Margin

‪12.29%‬

Operating Margin

‪16.17%‬

Return on Assets

‪9.71%‬

Return on Equity

‪26.01%‬

Ownership

Shares Outstanding

69.35M

Float

69.06M

Held by Insiders

‪0.32%‬

Held by Institutions

‪107.10%‬

Price stats

Beta

‪1.07‬

50-Day Avg

‪128.34‬

200-Day Avg

‪173.22‬

Dividends

Payout Ratio

‪0.00%‬

News Teaser - 1PODD - Insulet Corporation

News & Analysis

View all news

Market Cap - 1PODD - Insulet Corporation

Peers - 1PODD - Insulet Corporation

Peer Comparison

Compared with companies in Medical Devices listed on MTA.

Profile Summary - 1PODD - Insulet Corporation

About

Insulet Corporation is a medical device company focused on insulin delivery and diabetes management. Its flagship Omnipod platform includes wearable, tubeless insulin management systems designed to deliver continuous insulin without traditional pump tubing or multiple daily injections. The product line includes…

SectorHealthcare
IndustryMedical Devices
Employees5.40K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.